Newsfeeds - Spark Newswire

1 minute read

News

LEO Pharma and ICON Ink Deal to Propel Clinical Trial Execution Within Medical Dermatology

Today, 6:53 AM

LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ:ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric

ICLR

1 minute read

Baird Maintains Outperform on Icon, Raises Price Target to $285

By Benzinga Newsdesk

Today, 6:53 AM

Baird analyst Eric Coldwell maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $265 to $285.

ICLR

13 minute read

Earnings

Earnings Scheduled For February 22, 2023

By Benzinga Insights

Today, 6:53 AM

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

ACVA

1 minute read

Guggenheim Maintains Buy on Icon, Raises Price Target to $262

By Benzinga Newsdesk

Today, 6:53 AM

Guggenheim analyst Sandy Draper maintains Icon (NASDAQ:ICLR) with a Buy and raises the price target from $255 to $262.

ICLR

22 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 17, 2023

By Benzinga Insights

Today, 6:53 AM

Upgrades For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform.…

1 minute read

Barclays Upgrades Icon to Overweight

By Benzinga Newsdesk

Today, 6:53 AM

Barclays analyst Luke Sergott upgrades Icon (NASDAQ:ICLR) from Equal-Weight to Overweight.

ICLR

1 minute read

Baird Maintains Outperform on Icon, Raises Price Target to $265

By Benzinga Newsdesk

Today, 6:53 AM

Baird analyst Eric Coldwell maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $260 to $265.

ICLR

30 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 6:53 AM

During Wednesday's trading, 517 companies set new 52-week lows.

$APE

47 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 6:53 AM

On Tuesday, 838 companies hit new 52-week lows.

$APE

2 minute read

News

ICON Selected By BARDA To Conduct Anthrax Vaccine Clinical Trial

By Benzinga Newsdesk

Today, 6:53 AM

ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part

ICLR